Arintra has raised $25 million in Series B funding to expand its AI-powered healthcare revenue assurance platform, bringing the company’s total funding since inception to $51 million.
Define Ventures led the round, with participation from Peak XV Partners, Yale New Haven Health Center for Health Care Innovation, Endeavor Health Ventures, Y Combinator, Counterpart Ventures, Ten13 and Spider Capital.
The financing gives Arintra additional capital to expand across more health systems, medical specialties and revenue-cycle workflows as healthcare organizations increasingly use artificial intelligence to improve coding accuracy, reduce denials and capture revenue that might otherwise be lost.
Arintra’s platform currently processes more than $5 billion in annual claim value for healthcare organizations representing more than $50 billion in combined net patient revenue.
The company supports more than 23 specialties across ambulatory, emergency, diagnostic and inpatient care settings, giving its technology exposure to a broad range of medical coding and reimbursement workflows.
Healthcare revenue cycles can be highly complex because providers must translate clinical documentation into accurate billing codes while complying with payer rules, reimbursement policies and regulatory requirements.
Errors or inconsistencies in that process can result in denied claims, delayed payments, underbilling or increased administrative costs.
Arintra is using AI to automate parts of that process while helping health systems identify potential revenue leakage and improve coding compliance.
The company describes its approach as revenue assurance, reflecting a broader focus than simply automating medical coding.
The platform is designed to help providers ensure that services are coded accurately, billed appropriately and supported by the documentation required for reimbursement.
Arintra said customers using its technology have achieved a 5.1% increase in compliant revenue capture.
For large health systems processing billions of dollars in claims, even relatively small improvements in revenue capture can translate into meaningful financial benefits.
The company also reported that customers have achieved a 32% reduction in cost and a 43% decrease in coding-related denials.
Reducing denials is particularly important because rejected or disputed claims can require significant manual work from billing and coding teams before payment is ultimately collected.
Every denied claim can create additional administrative steps, including investigation, correction, resubmission and communication with insurers.
By identifying coding issues earlier and automating more of the review process, Arintra aims to reduce that burden.
The company is also targeting the labor-intensive auditing process used by healthcare organizations to evaluate coding quality and compliance.
UC Davis Health reported that it was able to complete auditing results approximately 50% faster using Arintra compared with traditional manual processes.
Faster audits can help health systems identify recurring coding problems sooner and provide feedback to clinical and revenue-cycle teams before those issues affect larger volumes of claims.
The technology could also allow coding and compliance professionals to spend less time reviewing routine cases and devote more attention to complex claims that require human judgment.
That combination of automation and human review is becoming increasingly important as health systems face pressure to control administrative expenses while maintaining regulatory compliance.
Revenue-cycle operations represent a particularly attractive area for healthcare AI because the workflows involve large amounts of structured and unstructured data, repetitive administrative tasks and complex rules that can create opportunities for automation.
At the same time, accuracy remains critical.
Incorrect coding can create financial losses for healthcare providers while also raising compliance risks if claims do not accurately reflect the services delivered.
Arintra’s reported 5.1% improvement in compliant revenue capture emphasizes that the company is seeking to increase reimbursement without sacrificing coding standards.
The Series B funding will allow Arintra to extend the platform into additional specialties and care environments.
Different medical specialties can have substantially different coding rules, clinical documentation requirements and reimbursement patterns.
Expanding across specialties therefore requires continued development of models and workflows capable of handling those differences.
The company also plans to expand into additional revenue-cycle functions.
Healthcare organizations manage numerous steps between delivering care and receiving payment, including documentation, coding, claim submission, denial management, payment reconciliation and auditing.
Extending Arintra’s AI platform across more of those processes could deepen its relationships with existing customers while increasing the amount of healthcare revenue flowing through its technology.
The company’s existing scale provides a substantial data and operating base for that expansion.
Processing more than $5 billion in annual claim value gives Arintra exposure to large volumes of real-world coding and reimbursement activity.
Its customers collectively generate more than $50 billion in net patient revenue, indicating that the platform is already being used by sizable healthcare organizations.
The participation of strategic healthcare investors in the Series B also reflects industry interest in technologies that can improve the economics of care delivery.
Yale New Haven Health Center for Health Care Innovation and Endeavor Health Ventures bring direct healthcare-system perspectives to the investor group.
Their participation could help Arintra better understand how AI tools need to integrate into existing health system workflows and technology environments.
Define Ventures’ leadership of the round also brings an investor focused on healthcare technology and services.
Peak XV Partners, Y Combinator, Counterpart Ventures, Ten13 and Spider Capital further broaden the company’s institutional backing.
With $51 million in total funding, Arintra now has additional resources to invest in product development, engineering, integrations and commercial expansion.
The company can also use the capital to support deployments at larger health systems, where implementation can require integration with electronic health records, billing platforms and other enterprise systems.
Healthcare organizations are increasingly interested in AI, but successful adoption depends heavily on measurable financial and operational outcomes.
Arintra’s reported improvements in revenue capture, cost reduction, denial rates and auditing speed provide metrics the company can use as it seeks additional customers.
The 43% reduction in coding-related denials is especially significant because denials remain a persistent challenge across the healthcare industry.
Insurers can reject claims for a wide variety of reasons, and providers often maintain large teams dedicated to investigating and appealing those decisions.
Reducing the number of claims that enter that process can improve both cash flow and administrative efficiency.
Similarly, the reported 32% cost reduction suggests that automation can help health systems manage revenue-cycle workloads with fewer manual interventions.
As hospitals face pressure from rising labor expenses and constrained operating margins, technologies that can improve administrative productivity may become increasingly attractive.
Arintra is positioning its platform around that combination of financial performance and operational automation.
Rather than functioning solely as an AI coding assistant, the company is attempting to provide infrastructure that helps health systems protect revenue throughout the reimbursement process.
The new Series B capital will support that strategy as Arintra expands beyond its current footprint of more than 23 specialties.
With more than $5 billion in annual claims already flowing through its platform and $51 million of total capital raised, the company is entering its next growth phase with increasing scale in a healthcare market where providers are looking for ways to use AI to reduce administrative costs, improve reimbursement and minimize avoidable claim denials.
KEY QUOTE:
“Revenue assurance isn’t optional anymore. It’s how health systems build a financial foundation that matches the quality of care they deliver.”
Nitesh Shroff, Co-Founder And CEO Of Arintra
